Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magnolia Optical Technologies is a high-technology research and development firm specializing in advanced optical materials and nanotechnology-based sensing solutions. The company focuses on the development of high-performance semiconductor materials, quantum dots, and nanostructured thin films for applications in defense, aerospace, and healthcare. In the life sciences sector, Magnolia develops ultrasensitive biosensors for the rapid detection of pathogens and biomarkers, as well as advanced imaging components for medical diagnostics. Their work is characterized by extensive collaboration with government agencies such as NASA and the Department of Defense, alongside leading academic institutions, to advance the state of optical and electronic device technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magnolia Optical Technologies.